Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line
Chen Wang,1,2 Qifeng Cao,2,* Shun Zhang,2,* Hailong Liu,2 Huangqi Duan,2 Weimin Xia,2 Haibo Shen,2 Cheng Wang1 1Department of Urology, The People's Hospital of SND, Suzhou, People's Republic of China; 2Department of Urology, Xinhua Hospital, Shanghai Jiaotong University Sch...
Saved in:
Main Authors: | Wang C (Author), Cao Q (Author), Zhang S (Author), Liu H (Author), Duan H (Author), Xia W (Author), Shen H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Localized amyloidosis of the urinary bladder, clinically masquerading as bladder cancer
by: DeSouza Maria, et al.
Published: (2008) -
Knowledge-map analysis of bladder cancer immunotherapy
by: Zongwei Lv, et al.
Published: (2023) -
Bladder Cancer Management of NMI and Muscle-Invasive Cancer
Published: (2017) -
Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer
by: Adnan Ahmad Ansari, et al.
Published: (2018) -
Strategies to Get Drugs across Bladder Penetrating Barriers for Improving Bladder Cancer Therapy
by: Shupeng Wang, et al.
Published: (2021)